AAAAAA

   
Results: 1-24 |
Results: 24
An open letter to the Committee on the Nobel Prize in Medicine
Authors: Abbruzzese, G Agid, Y Albanese, A Alf, C Allen, R Amar, K de Andrade, LA Ang, LC Angelini, C Archer, RL Arunodaya, GR Baltzan, M Baral, K Barnett, H Bergamasco, B Berger, M Bernard, J Bharucha, NE Bhatia, K Blary, N Black, S Bodis-Wollner, I Boyson, SJ Bral-Kulaksizoglu, I Brooks, DJ Brown, JD Burke, RE Calne, DOC Calne, SM Cardoso, F Cardozo-Pelaez, F Chang, YJ Chen, CC Chen, RS Chen, R Chowdhury, A Christie, S Chu, CC Chu, NS Clarida, L Collette, EM Comella, C Conneally, PM Crossman, AR Csanda, E Dalmau, J Dalvi, A De Feijter, A Deecke, L Desai, H De Ybenes, J Dihenia, B Direnfeld, L Dodel, R Donat, J Doudet, D Duane, DD Duff, J Duvoisin, R Eggert, K Elble, RJ Elmer, LW Emre, M Fariello, R Fernendy, HH Findley, LJ Fink, S Freissmuth, M Friedman, JH de la Fuente-Fernandez, R Furtado, S Furukawa, Y Galvez-Jimenez, N Gauthier, S Gawel, MJ Gilman, S Gladstone, RM Goetz, CG Gomori, A Gopinathan, G Gordin, A Gorell, JM Greenamyre, JT Grimes, DA Gurvit, H Guttman, M Guzman, DA Hachinski, V Hanagasi, H Hardy, J Harik, SJ Hassan, MN Hattori, N Hauser, RA Hayashi, H Heller, GL Hobson, D Hochschorner, G Hortnagel, H Horowski, R Howse, DC Huang, CC Huk, II Hurtig, H Hutton, JT Jaffe, ME Jankovic, J Jardine, M Jog, M Johnson, B Kagamihara, Y Karagoz, N Kasper, S Kato, S Kebabian, JW Kertsz, A Khadilkar, SV Kirk, A Kish, S Kitaguchi, T Kofman, OS Koide, R Komori, T Kostyuk, PG Kumar, R Kuo, HC Kurlan, R Kurland, L Kurtuncu, M Lalkaka, JA Lambert, M Landau, W Lang, AE Lassmann, H Lee, CS Lees, AJ Lieberman, A Litvan, I Loeb, C Logan, WJ Lozano, AM Lu, CS Lucy, D Lynch, T Manyam, BV Maraganore, D Marshall, FT Martin, WRW Martin, WE Mathias, C Matsubera, S Mendis, T Menkes, JH Metz, LN Miyazaki, Y Mizuno, Y Mohr, E Moodley, LG Moore, R Morris, JL Muthane, U Nagaraja, D Nair, CPV Narabayashi, H Nomura, Y Norris, JW Obeso, JA O'Brien, C Oertel, W Ohtake, T Okiyama, R Ozdemir, C Pal, PK Panisset, M Paty, DW Paulson, GW Perlmutter, J Pfeiffer, RF Pifl, C Pincus, JH Poewe, W Quinn, N Rajput, AH Rajput, A Ransmayr, G Rascol, O Robinson, R Rocca, WA Roos, RAC Rosenfeld, MR Russell, D Ruth, TJ Ryu, SJ Sachdev, H Safoschnik, G Sahin, H Sanchez-Ramos, J Satishchandra, P Schapira, A",Scheltens,"Schmidley, JW Schnaberth, G Schneider, E Schneider, JS Schutz, W Seeberger, LC Segawa, M Sethi, KD Shah, A Shannon, K Shelton, P Shihabuddin, B Shimizu, T Shinotoh, H Siddique, T Siderowf, A Sieghart, W Simard, A Simmonds, DC Singhal, BS Sluga, E Snow, BJ Soukop, W Sperk, G Spieker, S Steele, JC Stewart, S Stoessl, AJ Subramony, SH Sundaram, M Sung, CY Surya, N Sweet, RD Tabbal, SD Takahashi, H Taniguchi, M Tarsy, D Teravainen, H Tetrud, JW Tolosa, E Tourtellotte, WW Troupin, AS Tsui, JKC Tuite, P Uc, EY Ueki, Y Uitti, R Uyu, C van Hilten, JJ Veerendrakumar, M Veloso, F Viallet, F Voll, C Vrooman, M Wang, X Ward, I Ward, A Waters, C Weng, YH Wenning, GK Williams, BJ Wilson, TW Wolters, EC Wooten, FG Wszolek, Z Yahr, MD Yanagisawa, N Yokochi, F Young, RR Yu, CM Zifko, U
Citation: G. Abbruzzese et al., An open letter to the Committee on the Nobel Prize in Medicine, PARKINS R D, 7(2), 2001, pp. 149-155
Evaluation of antiparkinsonian drugs in pharmacy records as a marker for Parkinson's disease
Authors: van de Vijver, DAMC Stricker, BHC Breteler, MMB Roos, RAC Porsius, AJ de Boer, A
Citation: Damc. Van De Vijver et al., Evaluation of antiparkinsonian drugs in pharmacy records as a marker for Parkinson's disease, PHARM WORLD, 23(4), 2001, pp. 148-152
Quantitative assessment of daytime motor activity provides a responsive measure of functional decline in patients with Huntington's disease
Authors: van Vugt, JPP Siesling, S Piet, KKE Zwinderman, AH Middelkoop, HAM van Hilten, JJ Roos, RAC
Citation: Jpp. Van Vugt et al., Quantitative assessment of daytime motor activity provides a responsive measure of functional decline in patients with Huntington's disease, MOVEMENT D, 16(3), 2001, pp. 481-488
Impact of Huntington's disease on quality of life
Authors: Helder, DI Kaptein, AA van Kempen, GMJ van Houwelingen, JC Roos, RAC
Citation: Di. Helder et al., Impact of Huntington's disease on quality of life, MOVEMENT D, 16(2), 2001, pp. 325-330
Dementia in hereditary cerebral hemorrhage with amyloidosis-Dutch type is associated with cerebral amyloid angiopathy but is independent of plaques and neurofibrillary tangles
Authors: Natte, R Maat-Schieman, MLC Haan, J Bornebroek, M Roos, RAC van Duinen, SG
Citation: R. Natte et al., Dementia in hereditary cerebral hemorrhage with amyloidosis-Dutch type is associated with cerebral amyloid angiopathy but is independent of plaques and neurofibrillary tangles, ANN NEUROL, 50(6), 2001, pp. 765-772
Repetitive behaviors in Tourette's syndrome and OCD with and without ties:what are the differences?
Authors: Cath, DC Spinhoven, P Hoogduin, CAL Landman, AD van Woerkom, TCAM van de Wetering, BJM Roos, RAC Rooijmans, HGM
Citation: Dc. Cath et al., Repetitive behaviors in Tourette's syndrome and OCD with and without ties:what are the differences?, PSYCHIAT R, 101(2), 2001, pp. 171-185
Antipsychotic-induced extrapyramidal syndromes - Risperidone compared withlow- and high-potency conventional antipsychotic drugs
Authors: Schillevoort, I de Boer, A Herings, RMC Roos, RAC Jansen, PAF Leufkens, HGM
Citation: I. Schillevoort et al., Antipsychotic-induced extrapyramidal syndromes - Risperidone compared withlow- and high-potency conventional antipsychotic drugs, EUR J CL PH, 57(4), 2001, pp. 327-331
Gilles de la Tourette's syndrome with and without obsessive-compulsive disorder compared with obsessive-compulsive disorder without tics: Which symptoms discriminate?
Authors: Cath, DC Spinhoven, P Van Woerkom, TCAM Van de Wetering, BJM Hoogduin, CAL Landman, AD Roos, RAC Rooijmans, HGM
Citation: Dc. Cath et al., Gilles de la Tourette's syndrome with and without obsessive-compulsive disorder compared with obsessive-compulsive disorder without tics: Which symptoms discriminate?, J NERV MENT, 189(4), 2001, pp. 219-228
The relationship between types and severity of repetitive behaviors in Gilles de la Tourette's disorder and obsessive-compulsive disorder
Authors: Cath, DC Spinhoven, P van de Wetering, BJM Hoogduin, CAH Landman, AD van Woerkom, TCAM Roos, RAC Rooijmans, HGM
Citation: Dc. Cath et al., The relationship between types and severity of repetitive behaviors in Gilles de la Tourette's disorder and obsessive-compulsive disorder, J CLIN PSY, 61(7), 2000, pp. 505-513
Amyloid beta protein (A beta) starts to deposit as plasma membrane-bound form in diffuse plaques of brains from hereditary cerebral hemorrhage with amyloidosis-Dutch type, Alzheimer disease and nondemented aged subjects
Authors: Yamaguchi, H Maat-Schieman, MLC van Duinen, SG Prins, FA Neeskens, P Natte, R Roos, RAC
Citation: H. Yamaguchi et al., Amyloid beta protein (A beta) starts to deposit as plasma membrane-bound form in diffuse plaques of brains from hereditary cerebral hemorrhage with amyloidosis-Dutch type, Alzheimer disease and nondemented aged subjects, J NE EXP NE, 59(8), 2000, pp. 723-732
Family history and DNA analysis in patients with suspected Huntington's disease
Authors: Siesling, S Vegter-van de Vlis, M Losekoot, M Belfroid, RDM Maat-Kievit, JA Kremer, HPH Roos, RAC
Citation: S. Siesling et al., Family history and DNA analysis in patients with suspected Huntington's disease, J NE NE PSY, 69(1), 2000, pp. 54-59
Age-related plaque morphology and C-terminal heterogeneity of amyloid betain Dutch-type hereditary cerebral hemorrhage with amyloidosis
Authors: Maat-Schieman, MLC Yamaguchi, H van Duinen, SG Natte, R Roos, RAC
Citation: Mlc. Maat-schieman et al., Age-related plaque morphology and C-terminal heterogeneity of amyloid betain Dutch-type hereditary cerebral hemorrhage with amyloidosis, ACT NEUROP, 99(4), 2000, pp. 409-419
Memory and learning are not impaired in presymptomatic individuals with anincreased risk of Huntington's disease
Authors: de Boo, GM Tibben, A Hermans, J Jennekens-Schinkel, A Maat-Kievit, A Roos, RAC
Citation: Gm. De Boo et al., Memory and learning are not impaired in presymptomatic individuals with anincreased risk of Huntington's disease, J CL EXP N, 21(6), 1999, pp. 831-836
Hereditary cerebral hemorrhage with amyloidosis - Dutch type (HCHWA-D): a review of the variety in phenotypic expression
Authors: Bornebroek, M Haan, J Roos, RAC
Citation: M. Bornebroek et al., Hereditary cerebral hemorrhage with amyloidosis - Dutch type (HCHWA-D): a review of the variety in phenotypic expression, AMYLOID, 6(3), 1999, pp. 215-224
Huntington's disease - Options for controlling symptoms
Authors: van Vugt, JPP Roos, RAC
Citation: Jpp. Van Vugt et Rac. Roos, Huntington's disease - Options for controlling symptoms, CNS DRUGS, 11(2), 1999, pp. 105-123
Two centuries of mortality in ten large families with Huntington disease: A rising impact of gene carriership
Authors: Hille, ETM Siesling, S Vegter-van der Vlis, M Vandenbroucke, JP Roos, RAC Rosendaal, FR
Citation: Etm. Hille et al., Two centuries of mortality in ten large families with Huntington disease: A rising impact of gene carriership, EPIDEMIOLOG, 10(6), 1999, pp. 706-710
Analysis of the subcellular localization of huntingtin with a set of rabbit polyclonal antibodies in cultured mammalian cells of neuronal origin: comparison with the distribution of huntingtin in Huntington's disease autopsybrain
Authors: Dorsman, JC Smoor, MA Maat-Schieman, MLC Bout, M Siesling, S van Duinen, SG Verschuuren, JJGM den Dunnen, JT Roos, RAC van Ommen, GJB
Citation: Jc. Dorsman et al., Analysis of the subcellular localization of huntingtin with a set of rabbit polyclonal antibodies in cultured mammalian cells of neuronal origin: comparison with the distribution of huntingtin in Huntington's disease autopsybrain, PHI T ROY B, 354(1386), 1999, pp. 1061-1067
A review of the assessment of dyskinesias
Authors: Hoff, JI van Hilten, BJ Roos, RAC
Citation: Ji. Hoff et al., A review of the assessment of dyskinesias, MOVEMENT D, 14(5), 1999, pp. 737-743
Pathophysiology of chorea and bradykinesia in Huntington's disease
Authors: Berardelli, A Noth, J Thompson, PD Bollen, ELEM Curra, A Deuschl, G van Dijk, JG Topper, R Schwarz, M Roos, RAC
Citation: A. Berardelli et al., Pathophysiology of chorea and bradykinesia in Huntington's disease, MOVEMENT D, 14(3), 1999, pp. 398-403
Predictive testing of 25 percent at-risk individuals for Huntington disease (1987-1997)
Authors: Maat-Kievit, A Vlis, MV Zoeteweij, M Losekoot, M van Haeringen, A Roos, RAC
Citation: A. Maat-kievit et al., Predictive testing of 25 percent at-risk individuals for Huntington disease (1987-1997), AM J MED G, 88(6), 1999, pp. 662-668
Distribution of inclusions in neuronal nuclei and dystrophic neurites in huntington disease brain
Authors: Maat-Schieman, MLC Dorsman, JC Smoor, MA Siesling, S Van Duinen, SG Verschuuren, JJGM den Dunnen, JT Van Ommen, GJB Roos, RAC
Citation: Mlc. Maat-schieman et al., Distribution of inclusions in neuronal nuclei and dystrophic neurites in huntington disease brain, J NE EXP NE, 58(2), 1999, pp. 129-137
Amyloid beta precursor protein-mRNA is expressed throughout cerebral vessel walls
Authors: Natte, R de Boer, WI Maat-Schieman, MLC Baelde, HJ Vinters, HV Roos, RAC van Duinen, SG
Citation: R. Natte et al., Amyloid beta precursor protein-mRNA is expressed throughout cerebral vessel walls, BRAIN RES, 828(1-2), 1999, pp. 179-183
Ultrastructural evidence of early non-fibrillar A beta 42 in the capillarybasement membrane of patients with hereditary cerebral hemorrhage with amyloidosis, Dutch type
Authors: Natte, R Yamaguchi, H Maat-Schieman, MLC Prins, FA Neeskens, P Roos, RAC van Duinen, SG
Citation: R. Natte et al., Ultrastructural evidence of early non-fibrillar A beta 42 in the capillarybasement membrane of patients with hereditary cerebral hemorrhage with amyloidosis, Dutch type, ACT NEUROP, 98(6), 1999, pp. 577-582
Numerous and widespread alpha-synuclein-negative Lewy bodies in an asymptomatic patient
Authors: van Duinen, SG Lammers, GJ Maat-Schieman, MLC Roos, RAC
Citation: Sg. Van Duinen et al., Numerous and widespread alpha-synuclein-negative Lewy bodies in an asymptomatic patient, ACT NEUROP, 97(5), 1999, pp. 533-539
Risultati: 1-24 |